Department of Clinical Medicine

Infectious Diseases

Publications

Sort by: Date | Author | Title

Juelsgaard, J., Løfgren, B., Toxvig, N., Valsted Eriksen, G., Ebdrup, L. & Jensen, R. D. (2022). Healthcare professionals’ experience of using in situ simulation training in preparation for the COVID-19 pandemic: a qualitative focus group study from a Danish hospital. BMJ Open, 12(1), Article e056599. https://doi.org/10.1136/bmjopen-2021-056599
Dall, L. B., Deleuran, B., Østergaard, L. J., Mardahl, M., Denton, P. W. & Nejsum, P. (2022). Helminth products modulate innate immune recognition of nucleic acids in systemic lupus erythematosus. Lupus, 31(4), 415-423. https://doi.org/10.1177/09612033221080548
Whitehead, B., Christiansen, S., Østergaard, L. & Nejsum, P. (2022). Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy. Trends in Parasitology, 38(4), 277-279. https://doi.org/10.1016/j.pt.2022.01.007
Jakobsen, A., Skov, M. T., Larsen, L., Trier Petersen, P., Brandt, C., Wiese, L., Hansen, B. R., Lüttichau, H. R., Tetens, M. M., Helweg-Larsen, J., Storgaard, M., Nielsen, H., Bodilsen, J. & Danish Study Group of Infections of the Brain (2022). Herpes Simplex Virus 2 Meningitis in Adults: A Prospective, Nationwide, Population-Based Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75(5), 753-760. https://doi.org/10.1093/cid/ciab1071
Klastrup, V., Stærke, N. B. & Søgaard, O. S. (2022). Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization. Clinical Microbiology and Infection, 28(10), 1316-1318. https://doi.org/10.1016/j.cmi.2022.06.032
Thrysoee, L., Dyrehave, C., Christensen, H. M., Jensen, N. B. & Nielsen, D. S. (2022). Hospital nurses' experiences of and perspectives on the impact COVID-19 had on their professional and everyday life—A qualitative interview study. Nursing Open, 9(1), 189-198. https://doi.org/10.1002/nop2.1053
The ITAC (INSIGHT 013) Study Group (2022). Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. The Lancet, 399(10324), 530-540. https://doi.org/10.1016/S0140-6736(22)00101-5
Gubser, C., Chiu, C., Lewin, S. R. & Rasmussen, T. A. (2022). Immune checkpoint blockade in HIV. EBioMedicine, 76, Article 103840. https://doi.org/10.1016/j.ebiom.2022.103840
Bollerup, S., Engsig, F., Hallager, S., Mocroft, A., Roege, B. T., Christensen, P. B., Laursen, A. L., Krarup, H., Clausen, M. R., Thielsen, P., Madsen, L. G., Noerregaard, L., Barfod, T. S., Balslev, U., Tarp, B., Hansen, J. B., Mygind, L. H., Gerstoft, J. & Weis, N. (2022). Incidence of Hepatocellular Carcinoma and Decompensated Liver Cirrhosis and Prognostic Accuracy of the PAGE-B HCC Risk Score in a Low Endemic Hepatitis B Virus Infected Population. Journal of Hepatocellular Carcinoma, 9, 1093-1104. https://doi.org/10.2147/JHC.S372571
Paludan, S. R. & Mogensen, T. H. (2022). Innate immunological pathways in COVID-19 pathogenesis. Science Immunology, 7(67), Article eabm5505. https://doi.org/10.1126/sciimmunol.abm5505

Displaying results 551 to 560 out of 2082

Previous

52

53

54

55

56

57

58

59

60

61

Next

Revised 11.09.2025
-
Lotte Bjerregaard Snabe